Patent application number | Description | Published |
20090055149 | METHOD AND SYSTEM FOR DETERMINING ANALYTE LEVELS - Methods and apparatus for analyte level estimation are provided. | 02-26-2009 |
20090069649 | Method and System for Providing Analyte Monitoring - Methods and apparatuses for determining an analyte value are disclosed. | 03-12-2009 |
20090171178 | Method and System for Powering an Electronic Device - Methods and apparatuses for providing power supply to a device are provided. | 07-02-2009 |
20090198118 | Analyte Sensor with Time Lag Compensation - Methods and devices and systems for determining an analyte value are disclosed. | 08-06-2009 |
20090247857 | Analyte Sensor Calibration Management - Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results. | 10-01-2009 |
20090281407 | Method and System for Providing Analyte Monitoring - Methods and apparatuses for determining an analyte value are disclosed. | 11-12-2009 |
20100023291 | Method and System for Dynamically Updating Calibration Parameters for an Analyte Sensor - Methods and apparatuses including determining a calibration parameter associated with a detected analyte value, calibrating the analyte value based on the calibration parameter, and dynamically updating the calibration parameter are disclosed. Also provided are systems, kits, and computer program products. | 01-28-2010 |
20100057057 | Closed Loop Control And Signal Attenuation Detection - Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting a signal level associated with the monitored physiological condition deviating from a predetermined threshold level, retrieving the medication level administered associated with a time period of the detected signal level, applying the retrieved medication level to the detected signal based on a predefined predictive model to generate a predictive signal, and comparing the detected signal to the predictive signal to determine whether a condition associated with the detected signal level is present are provided. | 03-04-2010 |
20100064764 | Method and System for Providing Calibration of an Analyte Sensor in an Analyte Monitoring System - Method and apparatus for providing calibration of analyte sensor including applying a control signal, detecting a measured response to the control signal, determining a variance in the detected measured response, and estimating a sensor sensitivity based on the variance in the detected measured response is provided | 03-18-2010 |
20100191472 | Method and Device for Early Signal Attenuation Using Blood Glucose Measurements - Methods and devices to detect analyte in body fluid are provided. Embodiments include receiving one or more analyte sensor data, receiving a reference measurement value associated with an analyte level, determining a sensitivity parameter based on the received one or more analyte sensor data and the reference measurement value, performing a probability analysis based on prior analyte sensor data to determine presence of signal attenuation, and generating an output value based on the probability analysis. | 07-29-2010 |
20100295686 | USABILITY FEATURES FOR INTEGRATED INSULIN DELIVERY SYSTEM - Various systems and methods for improving the usability of continuous glucose monitors and drug delivery pumps are described. | 11-25-2010 |
20100298685 | ADAPTIVE INSULIN DELIVERY SYSTEM - A proactive system and method in which levels of glucose are monitored after a meal signal and compared to a safe range. If a monitored glucose level is outside the safe range, a post-prandial vertex of the glucose level is identified and an action is provided to more rapidly return the glucose level to a target level within the safe range than if no action was provided. In another aspect a control parameter in an IDM system is adjusted by determining a performance metric of the system as a function of the levels of glucose and a medication administration signal over a first window of time; and, if the performance metric is outside an expected range, adjusting the control parameter to adjust an amount of medication and to bring the performance metric inside the expected range. | 11-25-2010 |
20100298765 | SAFETY FEATURES FOR INTEGRATED INSULIN DELIVERY SYSTEM - Safety features are applied to an integrated insulin delivery system to enhance safety while accounting for glucose sensor bias and calibration errors. One safety feature includes comparisons of calibrations of the sensor to nominal sensitivity and taking action, such as limiting insulin delivery or taking a further calibration of the sensor. In another feature, an automatic resumption of a basal delivery rate is programmed into the delivery device to avoid the possibility of complete loss of delivery of insulin in the event that communication with the delivery device is disrupted. Other features include steps taken to avoid hypoglycemia in the event that the sensor is negatively biased. | 11-25-2010 |
20100317952 | METHODS FOR REDUCING FALSE HYPOGLYCEMIA ALARM OCCURRENCE - A system and method for reducing the number of hypoglycemic alarms presented to a user is presented. The system and methods include use of model based state estimation and variable-delayed threshold values to balance the risk of not presenting an alarm caused by an actual hypoglycemic state with the presentation of alarms caused by artifacts in the signals produced by a continuous glucose monitor. | 12-16-2010 |
20110098548 | METHODS FOR MODELING INSULIN THERAPY REQUIREMENTS - Various methods for improving the use of model based prediction of future blood glucose control in a patient having diabetes are described. A system for processing diabetes related information, including glucose information, for accurately predicting future glucose levels as a function of glucose data, carbohydrate intake, insulin delivery history and exercise history and then providing recommendations related to the predicted future glucose levels, is also described. | 04-28-2011 |
20110130746 | SAFETY LAYER FOR INTEGRATED INSULIN DELIVERY SYSTEM - An integrated diabetes management (IDM) system includes a safety layer which, in one configuration has two components, one located between a glucose sensor and a controller and a second component located between a controller and a pump, to monitor various aspects of signals and modify those signals for compatibility and safety purposes. In one application, the safety layer receives output control signals from a controller and modifies those control signals as a function of an actual amount of insulin delivered to the user. The safety layer allows for an increased level of safety in the IDM system and permits development of separate hardware and software upgrades with the safety layer assuring that compatibility between components will continue. | 06-02-2011 |
20120173200 | Method, System and Computer Program Product for Real-Time Detection of Sensitivity Decline in Analyte Sensors - Method, system and computer program product for providing real time detection of analyte sensor sensitivity decline is continuous glucose monitoring systems are provided. | 07-05-2012 |
20120239304 | Method and System for Determining Analyte Levels - Methods and apparatus for analyte level estimation are provided. | 09-20-2012 |
20120277565 | Method and System for Providing Analyte Monitoring - Methods and apparatuses for determining an analyte value are disclosed. | 11-01-2012 |
20120330227 | INTEGRATED INSULIN DELIVERY SYSTEM HAVING DELIVERY SAFETY FEATURES - An integrated insulin delivery system having safety features for controlling medication delivery includes automatic resumption of basal rate after a particular event, such as termination of a bolus, expiration of a time period, delayed resumption after the bolus has terminated, IOB comparison, and others. Other safety features include overriding a delivery control that may result in hypoglycemia, terminating an extended bolus or temporary basal rate in view of a glucose signal indicating imminent carbohydrate deficiency, and controlling the delivery rate to take an asymmetrical bias range of a glucose sensor into account to avoid hypoglycemia. | 12-27-2012 |
20130085679 | Methods, Devices and Systems for Analyte Monitoring Management - Methods of analyte monitoring management are provided. The methods include indicating on a user interface a plurality of analyte management procedures available for user-selection, where the plurality of analyte management procedures relate to analyte management parameters. Embodiments include receiving an indication to initiate a first procedure of the plurality of analyte management procedures, where the first procedure is for determining a first analyte management parameter. The methods may further include outputting user-instructions associated with the first procedure; receiving analyte measurement data for the first procedure; estimating the first analyte management parameter based on the analyte measurement data; calculating a degree of certainty for the estimation of the first analyte management parameter; and, initiating an action in response to an event associated with a status of the estimation of the first analyte management parameter or the degree of certainty. Analyte monitoring devices and systems implementing the methods are also provided. | 04-04-2013 |
20130096530 | METHOD OF MONITORING SAFETY IN MEDICATION DELIVERY FOR DIABETES MANAGEMENT - Glucose sensor signals and medication delivery control signals are monitored and these signals are modified for compatibility and safety purposes. In one application, output control signals from a controller directed to a delivery device are modified as a function of an actual amount of insulin delivered to the user. The safety layer method allows for an increased level of safety in an integrated delivery management (“IDM”) system and permits the development of separate hardware and software upgrades for components of the IDM system while assuring that compatibility between components will continue and safety is increased. | 04-18-2013 |
20130116527 | Analyte Sensor Calibration Management - Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results. | 05-09-2013 |
20130158376 | Temperature-Compensated Analyte Monitoring Devices, Systems, and Methods Thereof - Methods, devices and systems related providing accurate glucose levels in view of temperatures that may adversely affect glucose value. | 06-20-2013 |
20130304389 | Methods of Lag-Compensation for Analyte Measurements, and Devices Related Thereto - In some aspects, methods of lag compensation of analyte measurements are provided. Methods of lag-compensation are provided for analyte point measurements and/or for analyte rate-of-change measurements. The methods include receiving a series of uncompensated analyte measurements and determining parameter values for analyte point and/or rate-of-change estimates based on reference analyte measurements. The analyte rate-of-change estimate is based on a sum of a plurality of scaled rates-of-changes. The analyte point estimate is based on a sum of an analyte point and a sum of a plurality of scaled rates-of-changes. Devices related to the methods are also provided. | 11-14-2013 |
20140066890 | USABILITY FEATURES FOR INTEGRATED INSULIN DELIVERY SYSTEM - Various systems and methods for improving the usability of continuous glucose monitors and drug delivery pumps are described. | 03-06-2014 |
20140081236 | INTEGRATED CLOSED-LOOP MEDICATION DELIVERY WITH ERROR MODEL AND SAFETY CHECK - A closed-loop system for insulin infusion overnight uses a model predictive control algorithm (“MPC”). Used with the MPC is a glucose measurement error model which was derived from actual glucose sensor error data. That sensor error data included both a sensor artifacts component, including dropouts, and a persistent error component, including calibration error, all of which was obtained experimentally from living subjects. The MPC algorithm advised on insulin infusion every fifteen minutes. Sensor glucose input to the MPC was obtained by combining model-calculated, noise-free interstitial glucose with experimentally-derived transient and persistent sensor artifacts associated with the FreeStyle Navigator® Continuous Glucose Monitor System (“FSN”). The incidence of severe and significant hypoglycemia reduced 2300- and 200-fold, respectively, during simulated overnight closed-loop control with the MPC algorithm using the glucose measurement error model suggesting that the continuous glucose monitoring technologies facilitate safe closed-loop insulin delivery. | 03-20-2014 |
20140088392 | Feedback from Cloud or HCP to Payer or Patient via Meter or Cell Phone - Presented herein are one or more software applications to help a user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with an analyte measurement device. | 03-27-2014 |
20140088393 | Software Applications Residing on Handheld Analyte Determining Devices - Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device. | 03-27-2014 |
20140163460 | INTEGRATED DIABETES MANAGEMENT SYSTEM USING SAFETY LAYER - An integrated diabetes management (IDM) system includes a safety layer which, in one configuration has two components, one located between a glucose sensor and a controller and a second component located between a controller and a pump, to monitor various aspects of signals and modify those signals for compatibility and safety purposes. In one application, the safety layer receives output control signals from a controller and modifies those control signals as a function of an actual amount of insulin delivered to the user. The safety layer allows for an increased level of safety in the IDM system and permits development of separate hardware and software upgrades with the safety layer assuring that compatibility between components will continue. | 06-12-2014 |
20140180203 | INTEGRATED INSULIN DELIVERY SYSTEM HAVING SAFETY FEATURES TO PREVENT HYPOGLYCEMIA - Safety features are applied to an integrated insulin delivery system to enhance safety by controlling medication delivery including the automatic resumption of basal rate after a particular event, such as termination of a bolus, expiration of a time period, delayed resumption after the bolus has terminated, IOB comparison, and others. Other safety features include overriding a delivery control that may result in hypoglycemia, and terminating an extended bolus or temporary basal rate in view of a glucose signal indicating imminent carbohydrate deficiency. In another feature, an automatic resumption of a basal delivery rate is programmed into the delivery device to avoid the possibility of complete loss of delivery of insulin in the event that communication with the delivery device is disrupted. | 06-26-2014 |
20140187887 | GLYCEMIC RISK DETERMINATION BASED ON VARIABILITY OF GLUCOSE LEVELS - A system and method for determining glycemic risks based on an analysis of glucose data includes visualization of hypoglycemia, variability, and hyperglycemia with a control grid, increasing the accuracy of glucose estimates using a combination of CGM and HbAlc, calculating glycemic risk by applying a probability distribution, and tailoring SMBG test schedules based on CGM use/wear. | 07-03-2014 |
20140188400 | ANALYSIS OF GLUCOSE MEDIAN, VARIABILITY, AND HYPOGLYCEMIA RISK FOR THERAPY GUIDANCE - A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability. | 07-03-2014 |
20140350369 | SYSTEM AND METHOD TO MANAGE DIABETES BASED ON GLUCOSE MEDIAN, GLUCOSE VARIABILITY, AND HYPOGLYCEMIC RISK - A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment. | 11-27-2014 |
20150057636 | SYSTEM FOR MONITORING SAFETY IN MEDICATION DELIVERY FOR DIABETES MANAGEMENT - An integrated diabetes management (IDM) system includes a safety layer which, in one configuration has two components, one located between a glucose sensor and a controller and a second component located between a controller and a pump, to monitor various aspects of signals and modify those signals for compatibility and safety purposes. In one application, the safety layer receives output control signals from a controller and modifies those control signals as a function of an actual amount of insulin delivered to the user. The safety layer allows for an increased level of safety in the IDM system and permits development of separate hardware and software upgrades with the safety layer assuring that compatibility between components will continue. | 02-26-2015 |